Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
about
Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic EvidenceDiscrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.Modeling Combination HCV Prevention among HIV-infected Men Who Have Sex With Men and People Who Inject Drugs.Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study.The Hotel Study-Clinical and Health Service Effectiveness in a Cohort of Homeless or Marginally Housed Persons.Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting.Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting.Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis.The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.Population Health and Cost-Effectiveness Implications of a "Treat All" Recommendation for HCV: A Review of the Model-Based EvidenceHCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era
P2860
Q28072257-2343283C-BD2B-4415-B0A6-AB33AB9864EEQ33853905-D76EC86D-643F-41F4-9604-769E21D8DA33Q38769157-42E5941B-A03F-4F07-9D62-63347FB628C0Q38927743-057BA5E7-482B-4666-8F11-B64CB8933AF9Q38960176-383AE60D-4B42-4AFF-8784-2B9BBB8085AAQ39407573-3EB8DBF0-3FF6-4436-BB6E-02DBBB7D74F9Q40092669-1E12ED8A-F361-4B6C-BDAA-5A7C6131F719Q40118634-C7C78230-B811-4D55-B9AB-33979C59D86BQ47547780-62F0AFEB-BEEE-4ED3-AADF-6278D421332AQ52597017-7B38BEE5-ECDA-46B3-A8A1-11EBE17F162FQ53281101-44DAAC9E-67F6-4079-870D-9C0162AEF3C5Q55339576-BFF2EC47-FA83-498E-821D-BF83379CB667Q57145115-50068FD9-203B-4FC6-BDBA-97DD6CFE118FQ58775051-854B8F89-31AF-438E-8B2F-EDB353271765
P2860
Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Are Interferon-Free Direct-Act ...... among People Who Inject Drugs?
@ast
Are Interferon-Free Direct-Act ...... among People Who Inject Drugs?
@en
type
label
Are Interferon-Free Direct-Act ...... among People Who Inject Drugs?
@ast
Are Interferon-Free Direct-Act ...... among People Who Inject Drugs?
@en
prefLabel
Are Interferon-Free Direct-Act ...... among People Who Inject Drugs?
@ast
Are Interferon-Free Direct-Act ...... among People Who Inject Drugs?
@en
P2093
P2860
P50
P1433
P1476
Are Interferon-Free Direct-Act ...... among People Who Inject Drugs?
@en
P2093
Bohdan Nosyk
Eric Yoshida
Ignacio Rozada
Jason Grebely
Lillian Lourenco
Viviane D Lima
P2860
P304
P356
10.1371/JOURNAL.PONE.0143836
P407
P577
2015-12-03T00:00:00Z